Monday 13thFebruary 2023

We are pleased to invite investors and analysts to participate in our virtual event on Monday, 13February2023, highlighting Roche data presented at the virtual Angiogenesis, Exudation, and Degeneration 2023 Meeting, from 10th to 11th February.

16:30 - 18:00CET / 15:30-17:00GMT
10:30 - 12:00pm EST / 7:30 -9:00am PST

Agenda

  • Welcome - BrunoEschli, Head of Investor Relations
  • Roche ophthalmology strategy - Nilesh Mehta, Global Franchise Head of Ophthalmology
  • Roche ophthalmology pipeline - ChristopherBrittain, Vice President and Global Head of Ophthalmology Product Development
  • Key data presented at Angiogenesis - Veeral S.Sheth, MD, MBA, FASRS, FACS,Retina Specialist and Clinical Investigator

The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 15:30 CET on the day of the event.
>click here

Access to virtual event (pre-registration required)
Please pre-register for our webinar here *.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

A replay of the webcast will be available via >ir.roche.com

*privacy notice

Best regards,

Attachments

Disclaimer

Roche Holding AG published this content on 06 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 February 2023 13:09:06 UTC.